Abstract

Revised guidelines for the management of atrial fibrillation include new sections on dronedarone and aspirin–clopidogrel therapy, but dabigatran treatment is slated for an upcoming partial revision, according to the document.[1][1] The document was developed for the American College of Cardiology

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call